Posts Tagged IPO

SpaceX entered the Nasdaq-100 just 15 trading days after its IPO, triggering an estimated $4 billion in forced buying from index funds. The stock still fell about 7% and closed below its debut price. That was not a market failure. It was a reminder that widely anticipated demand is often priced in before the actual buying begins. When every participant can see the same trade coming, the event itself may become the exit rather than the catalyst. The real lesson is not that index inclusion failed. It is that mechanical demand does not guarantee upside when the market has already traded ahead of it.

Tokenized IPOs moved from theory to reality in 2026. Securitize’s NYSE listing showed how an issuer-sponsored token can represent the same underlying share on-chain, while new models from Backpack, Superstate, and Ondo are beginning to move IPO allocation and debut-day access onto Solana. With tokenized equity volume reaching roughly $3.86 billion in June, the infrastructure is taking shape. The next question is whether tokenization changes only how shares settle, or who gets access in the first place.

The market interpreted the reported OpenAI delay primarily through a macro lens, suggesting that the mega-IPO wave was slowing due to weakening public demand. However, this perspective may not be the most insightful. A more effective lens to consider is structure. If the reports are accurate, the inquiry posed to OpenAI was not about whether to go public at all, but rather whether to list sooner at a valuation below $1 trillion or to wait for market conditions that would support its desired valuation. Sam Altman reportedly viewed a reduction to that figure as unacceptable. This distinction is significant because it separates two concepts that are often conflated: investor appetite and entry point. A headline stating "OpenAI delays IPO" might imply a decrease in demand, but it could actually indicate a commitment to price discipline. The public market may still be interested in the company, but it may not be willing to meet the private-market valuation being proposed, which conveys a very different message.

Two weeks ago, the market's loudest fear was supply. SpaceX had just executed the largest IPO in history, raising approximately $75 billion at $135 a share, valuing the company near $1.77 trillion. Following closely were OpenAI and Anthropic, both anticipated to follow suit. The bearish narrative spread quickly: a wave of mega-listings could extract a trillion dollars of value from the broader market as investors sold existing holdings to fund new shares. However, this week, the anticipated wave began to slow down. OpenAI is reportedly considering delaying its IPO until 2027. Advisers have presented the company with a choice: list sooner at a valuation below $1 trillion or wait for more favorable conditions that align with its desired valuation. Sam Altman reportedly shows little interest in accepting a discount. The news caused a significant drop for SoftBank, one of OpenAI’s largest outside backers. This caution signals a shift in focus. The key question is no longer whether demand exists for these listings, but whether that demand will support the valuations seen in the private market.

OpenAI’s latest private funding round in March 2026 has set the company's valuation at approximately $852 billion. This valuation gap is significant, as it highlights the difference between OpenAI's current private mark and the anticipated IPO target, which is already in the hundreds of billions. However, a major challenge remains: access to OpenAI shares is limited. Currently, they are traded in a closed private market, primarily available to insiders, large funds, and accredited investors with the necessary connections. For the majority, the opportunity to engage with OpenAI may mirror the experience many had with SpaceX, arriving only after the market has already adjusted its valuation. Tessera changes this.

The line of mega-IPOs forming behind SpaceX includes a key player we have been closely monitoring, OpenAI. The significance of OpenAI is clear: it continues to hold the front door to AI technology. For many, ChatGPT represents their first substantial interaction with AI, which carries immense importance. The product reportedly engages around 900 million weekly users, maintaining a lead over any other AI-native product in terms of direct consumer reach. Although growth has slowed compared to the company's internal expectations, this should be taken seriously. Nevertheless, no competitor has matched the unique combination of scale, familiarity, and direct user engagement that OpenAI established first. This extensive reach does more than attract attention; it fosters distribution and builds a brand that the public recognizes. OpenAI also enjoys the broadest revenue opportunities among frontier labs, including consumer subscriptions, enterprise seats, and an API layer that supports thousands of downstream products. While many companies are developing impressive models, far fewer maintain a global relationship with end users at such scale.

Behind it are the AI labs. Two of the leading frontier AI companies are reportedly preparing 2026 listings and positioning themselves behind SpaceX. One appears to have moved first with a confidential filing. The other seems willing to wait, likely giving itself room to price against whatever the earlier deals establish. Together, they could be seeking well over $200 billion in proceeds from the same broad pool of capital, inside the same general window. That is where the real constraint starts to show. IPO timing is never chosen in isolation. It is chosen relative to every other company asking the market for money at the same time.

Reflecting on the evolution of the IPO process, there was a time when it was seen as an invitation for investors to join a company's journey early on. Companies like Amazon, AOL, and Google entered public markets at a stage where public shareholders could benefit significantly from their growth. However, the landscape has changed. Today, while the IPO still holds importance, its role has shifted. For many leading companies, the IPO is no longer the starting point of their value-creation narrative; instead, it often marks the conclusion of a highly lucrative phase. If you're interested in where the most substantial growth occurs, it's clear that public markets are witnessing it later than before. This represents a significant structural shift in how we view IPOs and growth potential.

The Nasdaq's new fast-entry rule has the potential to significantly alter the post-IPO trajectory for SpaceX. While this discussion initially focuses on SpaceX, it raises a broader question: could this be just the beginning? Looking ahead to 2026, we are witnessing the emergence of three mega-cap private companies preparing to enter the public market within a relatively short timeframe, collectively valued at nearly $4 trillion. SpaceX is anticipated to lead the way, with Anthropic likely targeting a later 2026 listing. OpenAI may also follow a similar timeline, although the exact order of these listings remains uncertain. This level of concentration is uncommon in any market cycle, and it is particularly noteworthy this time due to the recent changes in index rules.

Nasdaq's new fast-entry rule, which went live on May 1, significantly alters the timeline for very large IPOs. A newly listed company can now join the Nasdaq-100 after just 15 trading days if its market cap ranks within the top 40 existing constituents, eliminating the previous waiting period. This change has immediate implications for SpaceX. The anticipated IPO timeline suggests a public S-1 filing in the second half of May, followed by a roadshow starting in early June and a listing later that month. With a standard 180-day lock-up period expiring in the second half of December, SpaceX, valued between $1.75 trillion and $2 trillion, is likely to qualify for fast entry as soon as it becomes eligible. This adjustment creates a new dynamic for how the stock price may develop.